ArticleCell & bioscience2026
Unveiling a unique microglial phenotype promoting oxidation in the iBRB: insights from single-cell transcriptomics in the NPDR rat model.
Article in Cell & bioscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From M1/M2 polarization to disease-associated microglial states: refining the role of NIK in diabetic retinopathy.Journal of translational medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundEarly diagnosis and targeted treatment of inner blood-retinal barrier (iBRB) impairment in non-proliferative diabetic retinopathy (NPDR) present significant challenges. This study investigates the cellular heterogeneity and early lesions in the iBRB microenvironment.
methodsWe created a single-cell transcriptional atlas of NPDR using retinas from Zucker Diabetic Fatty rats, focusing on the expression of cells within the iBRB microenvironment, particularly microglia. We performed cell-cell gene interaction analyses to investigate intercellular communications among different cell types in the iBRB. Additionally, we conducted differentiation potential and trajectory analysis, transcription factor regulatory network characterization, and enrichment analysis of microglia. We also employed transmission electron microscopy, immunofluorescence, and histological analysis to validate the hypothesis.
resultsBased on retinal samples from NPDR rats which had retinal edema and kidney damage, and normal rats, we selected 36,821 cells for subsequent analysis using single-cell sequencing. We identified 669 cells in iBRB and microglia had the highest connectivity value by enrichment analysis. 980 differentially expressed genes related to microglia divide it into 4 subtypes. Among them, Spp1 highly expressed microglia subtype 2 had the highest differentiation potential and was significantly upregulated after NPDR lesions. By integrating histological and biochemical analysis results, the roles of the subtype in the differentiation of microglia in the iBRB microenvironment, such as oxidative stress and apoptosis, were well validated.
conclusionThis study identified a novel microglia type in NPDR rats, offering valuable insight into targeted therapeutic strategies for NPDR patients and enhancing our understanding of microglial regulation within the iBRB.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.